PEG-MGF – Pegylated Mechano Growth Factor-2mg

$59.00

PEG-MGF (PEGylated Mechano Growth Factor) is a chemically modified variant of MGF (Mechano Growth Factor / IGF-1Ec) in which a polyethylene glycol (PEG) chain is attached to extend circulation time and stability. This modification preserves MGF’s regenerative and anabolic properties while significantly prolonging its half-life in preclinical research. PEG-MGF is studied for its roles in muscle recovery, tissue protection, and regenerative medicine contexts.

SKU: BBT-US-30-699787
Products specifications
SPEC
2.0mg
FORM
Lyophilized powder
PRICE BREAKS - The more you buy, the more you save
Quantity 1+ 10+
Price $59.00 $42.00

1. What is PEG-MGF?

PEG-MGF (PEGylated Mechano Growth Factor) is a chemically modified variant of MGF (Mechano Growth Factor / IGF-1Ec) in which a polyethylene glycol (PEG) chain is attached to extend circulation time and stability. This modification preserves MGF’s regenerative and anabolic properties while significantly prolonging its half-life in preclinical research. PEG-MGF is studied for its roles in muscle recovery, tissue protection, and regenerative medicine contexts.


2. PEG-MGF Structure

Molecular FormulaC₁₂₁H₂₀₀N₄₂O₃₉ 

Molecular Weight2867.1g/mol

CAS Number221231-10-3


3. PEG-MGF Research

1Mechanism & Molecular Action

PEGylation benefits: Shielding from proteolysis and rapid renal clearance increases hydrodynamic size and prolongs peptide stability 1.

Myogenic signaling: Retains the MGF-associated activation of satellite cells (myoblast proliferation, differentiation, and fusion) described for the IGF-1Ec context2.

Cytoprotective pathways: Preclinical reports indicate activation of stress-response programs (e.g., antioxidant/Nrf2-linked transcription) 3.

2Preclinical Findings

Muscle regeneration: Animal studies of IGF-1Ec/MGF signaling show enhanced satellite-cell recruitment and muscle fiber recovery after load or injury (4).

Cardiac support: Controlled local release platforms (e.g., PEG-based hydrogels) are being explored for myocardial tissue support and remodeling in preclinical models (5).

Skeletal/soft-tissue repair: Reports in cartilage/bone models suggest improved chondrocyte/osteoblast activity and accelerated repair with IGF-axis peptides (6).

Neuroprotection: IGF-1Ec-related work indicates improved neuronal survival and adult neurogenesis in injury/aging models (7).


Why Consider PEG-MGF?

⏱️ Extended stability: PEGylation lengthens the effective research window versus native MGF.

🏋️ Myogenic support: Promotes satellite-cell activity and structural recovery in preclinical muscle studies.

❤️ Cardiac potential: Investigated with biomaterial delivery for myocardial tissue support.

🦴 Skeletal & joint: Explored for cartilage and bone repair in animal models.

🧠 Neuro-tissue resilience: Associated with improved neuronal survival and plasticity in preclinical settings.


4. Future PEG-MGF Research

Precision delivery: PEG/PEGDMA hydrogels and microrod systems for localized, sustained release in cardiac and orthopedic applications (8).

Dose & PK mapping: Larger-animal pharmacokinetics, biodistribution, and frequency optimization.

Comparative studies: Head-to-head evaluations versus other IGF-axis peptides or cell-based modalities for musculoskeletal repair.

Expanded indications: Preclinical exploration in sarcopenia, osteochondral repair, cardiomyopathy, neuroregeneration, and complex wound settings (9
10).

Mechanistic profiling: Transcriptomics/peptidomics to refine structure–activity and signaling (e.g., IGF-1R, Nrf2 pathways).

Clinical translation: First-in-human safety/PK studies will be needed to establish feasibility.


5. Application Areas

Sports medicine & recovery: Muscle repair/adaptation models post-overload.

Sarcopenia & aging biology: Satellite-cell support in age-related decline (preclinical).

Cardiac rehabilitation science: Myocardial tissue support using localized delivery platforms.

Orthopedics: Bone/fracture and tendon/ligament repair models.

Wound & soft-tissue care: Tissue remodeling and microenvironment support.

Neuroregeneration: Injury/ischemia models assessing neuronal survival and plasticity.


Summary

PEG-MGF is a PEGylated analog of Mechano Growth Factor designed to overcome the rapid clearance of native MGF and extend functional stability in research. Across preclinical systems, PEG-MGF-related work points to enhanced myogenesis, tissue protection, and potential utility with localized biomaterial delivery. Future priorities include precise delivery engineering, rigorous pharmacology/safety mapping, and eventual clinical translation to define real-world applicability.


Disclaimer

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.
The products offered on this website are furnished for in-vitro studies only (in vitro = outside of the body). These products are not medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.

 

Only registered users can write reviews